OEC
Live / Registered — Registered (as of 13 Dec 2022)
What this means for you
Registered since 13 Dec 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90708918
- Registration number
- 6926111
- Mark type
- Stylized text
- Filed
- 13 May 2021
- Published for opposition
- 25 Jan 2022
- Registered
- 13 Dec 2022
- Attorney of record
- Christina M. Licursi, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, none of the foregoing including omega fatty acids
Owner
- Omega Therapeutics, Inc., CAMBRIDGE, MA, US
- Omega Therapeutics, Inc., Cambridge, MA, US
- Omega Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 01 Jun 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Jun 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 01 Jun 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 Jun 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 01 Jun 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 13 Dec 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Dec 2022 — REGISTERED-PRINCIPAL REGISTER
- 05 Nov 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Nov 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Oct 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Sept 2022 — USE AMENDMENT FILED
- 05 Oct 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Sept 2022 — TEAS STATEMENT OF USE RECEIVED
- 22 Mar 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Jan 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED